These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 33563159)

  • 1. Targeting Cancer Stem Cells with Repurposed Drugs to Improve Current Therapies.
    Fong D; Christensen CT; Chan MM
    Recent Pat Anticancer Drug Discov; 2021; 16(2):136-160. PubMed ID: 33563159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cancer stem cells with dietary phytochemical - Repositioned drug combinations.
    Chan MM; Chen R; Fong D
    Cancer Lett; 2018 Oct; 433():53-64. PubMed ID: 29960048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance.
    Keyvani-Ghamsari S; Khorsandi K; Rasul A; Zaman MK
    Clin Epigenetics; 2021 May; 13(1):120. PubMed ID: 34051847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing drugs as pro-oxidant redox modifiers to eliminate cancer stem cells and improve the treatment of advanced stage cancers.
    Ralph SJ; Nozuhur S; ALHulais RA; Rodríguez-Enríquez S; Moreno-Sánchez R
    Med Res Rev; 2019 Nov; 39(6):2397-2426. PubMed ID: 31111530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease.
    Lamb R; Ozsvari B; Lisanti CL; Tanowitz HB; Howell A; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Oncotarget; 2015 Mar; 6(7):4569-84. PubMed ID: 25625193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic approaches targeting cancer stem cells.
    Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
    J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can nanomedicines kill cancer stem cells?
    Zhao Y; Alakhova DY; Kabanov AV
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1763-83. PubMed ID: 24120657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Existing drugs and their application in drug discovery targeting cancer stem cells.
    Lv J; Shim JS
    Arch Pharm Res; 2015 Sep; 38(9):1617-26. PubMed ID: 26152874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Stem Cells and their Management in Cancer Therapy.
    Shenouda S; Kulkarni K; Abuetabh Y; Sergi C
    Recent Pat Anticancer Drug Discov; 2020; 15(3):212-227. PubMed ID: 32660407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy.
    Das PK; Zahan T; Abdur Rakib M; Khanam JA; Pillai S; Islam F
    Anticancer Agents Med Chem; 2019; 19(15):1796-1808. PubMed ID: 31272363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs].
    Mashima T
    Yakugaku Zasshi; 2017; 137(2):129-132. PubMed ID: 28154319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing of Anticancer Stem Cell Drugs in Brain Tumors.
    Bahmad HF; Daher D; Aljamal AA; Elajami MK; Oh KS; Alvarez Moreno JC; Delgado R; Suarez R; Zaldivar A; Azimi R; Castellano A; Sackstein R; Poppiti RJ
    J Histochem Cytochem; 2021 Dec; 69(12):749-773. PubMed ID: 34165342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015).
    Kharkar PS
    Expert Opin Ther Pat; 2017 Jul; 27(7):753-761. PubMed ID: 28460551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing of Metformin for Cancer Therapy: Updated Patent and Literature Review.
    Ahmed ZSO; Golovoy M; Abdullah Y; Ahmed RSI; Dou QP
    Recent Pat Anticancer Drug Discov; 2021; 16(2):161-186. PubMed ID: 34132186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors.
    Hong IS; Lee HY; Nam JS
    Recent Pat Anticancer Drug Discov; 2015; 10(1):2-22. PubMed ID: 25479037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria in cancer stem cells: a target for therapy.
    Loureiro R; Mesquita KA; Oliveira PJ; Vega-Naredo I
    Recent Pat Endocr Metab Immune Drug Discov; 2013 May; 7(2):102-14. PubMed ID: 23360288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugs.
    Vojnits K; Feng Z; Johnson P; Porras D; Manocha E; Vandersluis S; Pfammatter S; Thibault P; Bhatia M
    Cancer Lett; 2024 Sep; 599():217108. PubMed ID: 38986735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-Sensitizing Tumor Cells to Cancer Drugs with Epigenetic Regulators.
    Rauscher S; Greil R; Geisberger R
    Curr Cancer Drug Targets; 2021; 21(4):353-359. PubMed ID: 33423645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.